Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
Appointed director
Inv. presentation
Appointed CFO
PDL BIOPHARMA, INC. (PDLI) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/10/2023 SC 13G/A DIMENSIONAL FUND ADVISORS LP reports a 6.5% stake in PDL BioPharma Inc
02/08/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/26/2021 10-K Annual Report for the period ended December 31, 2020
02/19/2021 SC TO-I/A Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2021 EFFECT Form EFFECT - Notice of Effectiveness:
02/04/2021 EFFECT Form EFFECT - Notice of Effectiveness:
02/04/2021 EFFECT Form EFFECT - Notice of Effectiveness:
02/04/2021 EFFECT Form EFFECT - Notice of Effectiveness:
02/04/2021 EFFECT Form EFFECT - Notice of Effectiveness:
02/04/2021 EFFECT Form EFFECT - Notice of Effectiveness:
02/04/2021 EFFECT Form EFFECT - Notice of Effectiveness:
02/02/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2021 EFFECT Form EFFECT - Notice of Effectiveness:
02/02/2021 EFFECT Form EFFECT - Notice of Effectiveness:
02/01/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/01/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/15/2021 SC TO-I Form SC TO-I - Tender offer statement by Issuer:
01/11/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
01/11/2021 SC 13G/A Park West Asset Management LLC reports a 12.6% stake in PDL Biopharma, inc.
01/08/2021 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
12/28/2020 25 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
12/14/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL’s Previously Announced Settlement Agreement with Wellstat"
12/08/2020 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
Docs: "PDL Announces Timeline for Voluntarily Delisting from Nasdaq Expects to File a Certificate of Dissolution on January 4, 2021 Trading in PDL’s Common Stock on Nasdaq to be Suspended Prior to Market Opening on December 31, 2020"
11/09/2020 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
10/07/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy